Atlas Trials

Stage IB Non-Small Cell Lung Carcinoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IB Non-Small Cell Lung Carcinoma

RecordFirmDate
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer (NCT03366766)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2017-12-20
Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer (NCT03091816)University of Southern California2017-05-08
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) (NCT02728596)SWOG Cancer Research Network2016-10-07
SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer (NCT02581787)Maximilian Diehn2016-08-01
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer (NCT05979623)Shanghai Zhongshan Hospital2016-01-01
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery (NCT01886573)National Cancer Institute (NCI)2013-06-01
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer (NCT01342770)National Cancer Institute (NCI)2011-04-01
Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery (NCT01207726)National Cancer Institute (NCI)2010-09-01
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC (NCT00963807)National Cancer Institute (NCI)2009-09-01
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer (NCT02154399)National Cancer Institute (NCI)2002-05-01

Track Stage IB Non-Small Cell Lung Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.